semaglutide and eye disease Ozempic linked to higher risk of rare blinding condition Semaglutide Medications and Eye Health

Phillips, C

doi:10.1016/s1357-2725(00)00087-x Compliance Statement This product is intended for laboratory research use only and is not approved for human or veterinary use

GLP-1R agonist treatment induced insulin-like growth factor-2 secretion and promoted expression of its receptor, which has been suggested to enhance the pro-survival actions of GLP-1 in islet beta-cells

If youre considering weight loss medication, you likely have questions about what results you can expect and how they fit into your overall body transformation plan

References Abdelrazik H, Sharma R, Mahfouz R, Agarwal A.2009

doi:10.1016/j.diabres.2023.110669